Cangzhou Mingzhu Plastic (002108.SZ) has received approval from the Shenzhen Stock Exchange's Listing Review Center for its application for a private placement of shares.
Cangzhou Mingzhu (002108.SZ) announced that on September 2, 2026, it received a notice from the Listing Review Center of the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") regarding the "Opinion Notification Letter on the Application of Cangzhou Mingzhu Plastic Co., Ltd. for the Issuance of Stocks to Specific Objects." The issuance and listing review agency of the SZSE reviewed the application documents for the company's issuance of stocks to specific objects and concluded that the company meets the conditions for issuance, listing requirements, and information disclosure requirements. Subsequently, the SZSE will report to the China Securities Regulatory Commission (hereinafter referred to as "CSRC") as required to carry out the relevant registration procedures.
Cangzhou Mingzhu Plastic (002108.SZ) announced that on September 2, 2026, it received a notification letter from the Listing Examination Center of the Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange") regarding the review opinion on the application of Cangzhou Mingzhu Plastic Co., Ltd. for issuing shares to specific objects. The issuance and listing review agency of the Shenzhen Stock Exchange has reviewed the company's application documents for issuing shares to specific objects and believes that the company meets the issuance conditions, listing conditions, and information disclosure requirements. Subsequently, the Shenzhen Stock Exchange will report to the China Securities Regulatory Commission (hereinafter referred to as "CSRC") as required to carry out the relevant registration procedures.
Related Articles
HUTCHMED (00013): Reached a licensing agreement with GlaxoSmithKline for KRAS-EGFR antibody-drug conjugates for cancer treatment.
GEELY AUTO (00175) issued 40,500 shares due to the exercise of stock options.
HK Stock Market Move | SEER TECH (06106) surged over 7% in early trading as the company was included in the Hang Seng Composite Index, with the prospect of entering the Stock Connect program.
HUTCHMED (00013): Reached a licensing agreement with GlaxoSmithKline for KRAS-EGFR antibody-drug conjugates for cancer treatment.
GEELY AUTO (00175) issued 40,500 shares due to the exercise of stock options.
HK Stock Market Move | SEER TECH (06106) surged over 7% in early trading as the company was included in the Hang Seng Composite Index, with the prospect of entering the Stock Connect program.
RECOMMEND
